- $285.14m
- $165.06m
- $16.92m
- 50
- 35
- 29
- 31
Annual income statement for Gevo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5.54 | 0.533 | 1.18 | 17.2 | 16.9 |
| Cost of Revenue | |||||
| Gross Profit | -9.47 | -7.15 | -12.1 | 1.17 | 1.95 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 35.1 | 60.2 | 104 | 99 | 108 |
| Operating Profit | -29.6 | -59.6 | -103 | -81.8 | -90.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -40.2 | -59.2 | -98 | -66.2 | -78.6 |
| Net Income After Taxes | -40.2 | -59.2 | -98 | -66.2 | -78.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -40.2 | -59.2 | -98 | -66.2 | -78.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -40.2 | -59.2 | -98 | -66.2 | -78.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.644 | -0.279 | -0.328 | -0.277 | -0.318 |